In the competitive FDA and USDA space, mergers and acquisitions of brands and companies lead to increased synergies and market share. Without careful and early due diligence assessments, however, these transactions can also increase exposure to regulatory risk. Having a clear and unbiased picture of the state of regulatory and quality compliance is a critical part of an overall due diligence assessment.
EAS Consulting Group’s due diligence services support regulatory and compliance reviews of Private Equity (PE)/Venture Capital (VC) mergers and acquisitions. Our in-depth compliance, quality and regulatory risk assessments detail any gaps and necessary corrective actions, offering a complete and unbiased picture of regulatory and quality compliance exposure to FDA enforcement, which can have far reaching and potentially negative financial implications.
Our findings are captured in a detailed report and include a summary of observations, their criticality, and recommended corrective actions that should be considered either prior to or after the transaction.
EAS Consulting Group’s audits are customizable to your needs and goals and can be conducted on short notice and may, in part, be done virtually. We review, assess, and identify issues regarding prior FDA enforcement actions, state of compliance with FDA and USDA current GMP regulations, supplier management, equipment operations and training standards, inappropriate marketing and claims statements, and compliance with appropriate FDA or USDA facility and laboratory regulations. Additionally, through our strategic alignment with Certified Laboratories, we can facilitate any product testing requirements.
EAS welcomes the opportunity to discuss your due diligence needs and how we may support you. Whether as part of a broader M&A effort or an internal review in preparation for an acquisition, EAS and Certified Laboratories offer a reliable, rapid, flexible, comprehensive, accurate and customizable portfolio of due diligence services.
Download our Due Diligence and M&A Regulatory Support Service Sheet here and learn more about our Virtual Consulting Services here. We also support Food and Drug attorneys and in-house counsel through Due Diligence Assessments and Expert Witness Services for litigation matters. Contact Dean Cirotta, EAS President at 571-447-5508.
Posted in Press Release.